Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Gastroenterology | Internal Medicine | Nursing | Oncology | Pathology | Journal

Back to Journal Articles

Neurogenesis Indicative of Poor Colorectal Cancer Outcomes

Last Updated: October 28, 2011.

 

Worse overall, disease-free survival for tumors exhibiting high degrees of neurogenesis

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Neurogenesis is associated with colorectal cancer progression, and is predictive of poor outcomes for patients, according to a study published in the Nov. 1 issue of Cancer.

FRIDAY, Oct. 28 (HealthDay News) -- Neurogenesis is associated with colorectal cancer progression, and is predictive of poor outcomes for patients, according to a study published in the Nov. 1 issue of Cancer.

Daniel Albo, M.D., Ph.D., from the College of Medicine in Houston, and colleagues investigated whether neurogenesis is indicative of an aggressive tumor phenotype in colorectal cancer. Samples were obtained from 236 patients to create a tissue array and database. Immunostaining of slides with protein gene product 9.5 was used to identify nerve tissue. The association between markers of neurogenesis and oncologic outcomes was examined, and the effect of colorectal cancer cells on stimulation of neurogenesis in vitro was assessed.

The investigators identified 50 percent reductions in five-year overall survival and disease-free survival for patients whose tumors exhibited high degrees of neurogenesis compared with those whose tumors contained no detectable neurogenesis. Significantly greater reductions in five-year overall and disease-free survival were seen in patients with stage II disease and high degrees of neurogenesis, than in lymph node-negative patients with no neurogenesis. Significantly lower five year overall and disease-free survival was found in patients with stage II disease and high degrees of neurogenesis, than those with stage III disease with no neurogenesis. Neurogenesis was stimulated in colorectal cancer cells and there was evidence of neuroepithelial interactions between nerves and tumor cells in vitro.

"Neurogenesis is indicative of poor survival and recurrence and is an independent prognostic factor for poor outcomes in colorectal cancer," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.


Previous: Weight Loss in Obese Tied to Low-Order Cognitive Upturn Next: Fecal Assays Help Identify Food Hypersensitivity in IBS

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.